942928

Hikma Pharmaceuticals USA, Inc. — FEI 2250102

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 10, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Eatontown, NJ (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)